News

With increased infectivity of Omicron, the Centers for Control and Prevention (CDC) has updated the guidance on the best mask types to use.

Clinicians need to avoid negative terms in describing patients

Will Kirby, DO, FAOCD, board-certified dermatologist, chief medical officer of LaserAway, and Dermatology Times® editorial board member, will be speaking at the Medical Spa Show, presented by the American Med Spa Association.

In this week’s Pointers with Dr Portela, the 208SkinDoc dives into a social media video that shows someone advocating for urine for hair, skin, and overall body care. See what he has to say about this suggestion.

Vial announced an advisory board to discuss dermatology CROs at the 2022 Winter Clinical Dermatology Conference.

Click here to answer this week's poll.

AAD vice president challenges dermatologists to advocate for their patients and themselves.

Resident billing can have huge financial implications on academic institutions. A poster from the Icahn School of Medicine at Mount Sinai aimed to assess new medical coding lectures and a modified note template at Winter Clinical Dermatology Conference.

ICYMI, this week we had stories on Vial's CRO launch, our conference coverage coming up this weekend, and more.

Several talks expected to focus on the latest treatment updates, as well as some recently published data on COVID-19 symptoms and a commonly-used atopic dermatitis treatment.

Energy and autos lead the way, health care relatively stable

Vial launches Vial Dermatology contract research organization (CRO) and highlights how it could improve the speed and quality of clinical trials.

A national survey found that patients are willing to try medical cannabis products as potential treatments of their condition. Additionally, some already use over-the-counter cannabis products.

The new year promises to be rich with dermatology game changers following a sluggish 2021 for breakthroughs and FDA approvals.

Click to see a preview of what to expect this week.

ICYMI, this week we had stories on the continued issues with iPLEDGE, the new data on spesolimab treatment for GPP, and more.

The Skin of Color Society released an article detailing its 2021 achievements, containing what the society considers its most active and successful year.

But mask-wearing still vital to slowing spread of disease, agency says.

Click to see a preview of what to expect this week.

ICYMI, some of this week’s featured content includes an exclusive interview about lasers and acne, and articles on 2021's top 20 stories, the declining preference for telehealth, and more.

Dermatology Times® broke the news that the carcinogen benzene was found in multiple sunscreens, but that wasn’t the only major headline of the year. We revisit the 20 stories of 2021 that made the greatest impact.

Two possible explanations for declining contentment with live video calls as a form of care delivery.

A recent study investigates the probability of BDD in cosmetic dermatology with the help of a new screening tool.

This week's edition of the Mainstream Patients features stories about the best hair removal methods, pH levels in the skin, and more.

Click to see a preview of what to expect this week.

Don't Forget to take this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about the occupational dermatoses, and articles on 2021's breakthroughs and disappointments, the risk of psoriasis related to BMI and more.

Click to see a preview of what to expect this week.

Click here to answer this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about the iPLEDGE program issues, and articles on FDA approval of upadacitinib for psoriatic arthritis, ruxolitinib cream receiving Priority Review from the FDA for vitiligo, and more.